Newsbriefs: Mind & Memory

Promising New Alzheimer’s Drug in Development In a phase 2 clinical trial, an investigational drug, BAN2401 (Eisai, Japan; and Biogen, United States), administered at a dosage of 10 mg/kg biweekly significantly slowed the progression of Alzheimer’s disease and reduced the amount of accumulated beta-amyloid, a protein that forms plaques in the brains of people with […]


Leave a Reply

Enter Your Log In Credentials
This setting should only be used on your home or work computer.